- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Rear Admiral Dr Wanda Barfield Discusses Initiatives That Led to the Decrease of Teen Pregnancy
Rear Admiral Wanda Barfield, MD, MPH, director of the Division of Reproductive Health for the CDC, discusses the initiatives that have played a role in the decrease of teen pregnancy in the United States.
Rear Admiral Wanda Barfield, MD, MPH, director of the Division of Reproductive Health for the CDC, discusses the initiatives that have played a role in the decrease of teen pregnancy in the United States.
Transcript
Under the Affordable Care Act, there has been a significant decrease in teen pregnancy. What initiatives have played a role in this decrease, and how has increased access to long-acting reversible contraceptives affected this population?
So, with regard to increasing access to postpartum contraception, it's important to know that there have been a variety of evidence-based activities that have contributed to the reduction in teen pregnancy rates in the United States.
We've seen the lowest reported rates of teen pregnancy as well as some reductions in disparities. These efforts have been through multi-component community-wide initiatives and other activities that have helped to reduce teen pregnancy.
Increasing the awareness of long-acting reversible contraception is one of the several strategies that have been important to reducing teen pregnancy.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Finding the Right Biomarker Is Key to the TIGIT Puzzle, Experts Say
May 12th 2025Data for SKYSCRAPER-01, involving the anti-TIGIT antibody tiragolumab, align with recent bad news for this once-promising therapeutic target. But investigators involved in TIGIT studies say the problem is finding the right biomarker.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Addressing KRAS Resistance, RAS(ON) Therapies Find Limelight at AACR
May 5th 2025KRAS-targeted therapies, including daraxonrasib and zoldonrasib, show promise in overcoming resistance in cancer treatment, as highlighted at the 2025 meeting of the American Association for Cancer Research (AACR).
Read More
